摘要恶性胸腔积液(malignant pleural effusion,MPE)是一种常见的肺癌晚期并发症,15％的肺癌患者有胸腔积液,且约50％的患者出现胸腔积液是在肺癌晚期.肺癌患者一旦出现胸腔积液即意味着病变已局部或全身播散,患者的生存期缩短、生活质量明显下降.MPE目前无特异的治疗方法.Th9细胞和Th17细胞在抗肿瘤免疫中发挥了重要作用,下面就MPE中Th9细胞和Th17细胞的相关研究作一综述.

abstractsMalignant pleural effusion (MPE) was an common complication of advanced lung cancer,which occured in 15 ％ of the lung cancer patients,and 50％ of the patients developed MPE at the later stage.Once MPE appeared in lung cancer patients,it indicated that cancer had spread whole or part of the body,life expectancy was shorten,and quality of life was poor.There were nonspecific treatments to MPE.Th9 cell and Th17 cell played an important role in antitumor immunization.Here we make a review to the related study about Th9 cell and Th17 cell in MPE.